Coherus BioSciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide.
View all
Dynavax Technologies
Post IPO Debt • Emeryville, United States
Revance Therapeutics
Post IPO Debt • Newark, United States
Cytokinetics
Post IPO Debt • South San Francisco, United States
Travere Therapeutics
Post IPO Debt • San Diego, United States
Myovant Sciences
Post IPO Debt • Brisbane, United States
MeiraGTx
Post IPO Debt • New York, United States
Avid Bioservices
Post IPO Debt • Tustin, United States
CTI BioPharma
Post IPO Debt • Seattle, United States
Geron
Post IPO Debt • Menlo Park, United States
Desktop Metal
Post IPO Debt • Burlington, United States
Sunnova Energy
Post IPO Debt • Houston, United States
Eiger BioPharmaceuticals
Post IPO Debt • Palo Alto, United States